{"symbol":"BSX","fiscalQuarter":"Q3-2013","reportDate":"2013-10-24","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2013","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 6.1%","keyNumbers":[{"metric":"EPS","actual":"$0.17","expected":"N/A","surprise":"+8.97%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","The company remains focused on long-term growth strategies."],"summary":"Management highlighted the positive EPS surprise as a sign of resilience. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No guidance data is available for future performance expectations.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell 6.1% in reaction, likely due to the lack of revenue information and future guidance. Investors may be cautious as they await more clarity on the company's performance outlook.","metaDescription":"Boston Scientific (BSX) Q3 2013 earnings: EPS beat by 8.97%. Stock down 6.1%. Full breakdown."}}